Citalopram use in pregnancy: Prospective comparative evaluation of pregnancy and fetal outcome

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 6, 2005, Pages 2004-2009

  Sivojelezova, Anna ^a,b   Shuhaiber, Samar ^a   Sarkissian, Lorig ^a   Einarson, Adrienne ^a   Koren, Gideon ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Citalopram; Poor neonatal adaptation; Pregnancy outcome; Selective serotonin reuptake inhibitor

Indexed keywords

CITALOPRAM;

ABORTION; ADAPTATION SYNDROME; ADULT; ARTICLE; BIRTH WEIGHT; BRADYCARDIA; BREATHING DISORDER; CONFIDENCE INTERVAL; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOWN SYNDROME; DRUG SAFETY; ECTOPIC PREGNANCY; EMBRYO DEVELOPMENT; FEMALE; FETUS DISTRESS; FETUS HEART RATE; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HEART ATRIUM SEPTUM DEFECT; HEART RATE VARIABILITY; HUMAN; HYPOSPADIAS; MAJOR CLINICAL STUDY; MECONIUM ASPIRATION; MECONIUM STAINING; MOTHER; NEWBORN DISEASE; NURSERY; PNEUMOTHORAX; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DISORDER; PREMATURITY; PRIORITY JOURNAL; SCROTUM DISORDER; SCROTUM HERNIA; SPONTANEOUS ABORTION; STILLBIRTH; SURVIVAL RATE; TERATOGENESIS; UMBILICAL HERNIA;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIRTH WEIGHT; CITALOPRAM; FEMALE; GESTATIONAL AGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; SEROTONIN UPTAKE INHIBITORS;

EID: 28444474891     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.05.012     Document Type: Article

References (33)

1. K.L. Wisner, D.A. Zarin, E.S. Holmboe, P.S. Appelbaum, A.J. Gelenberg, and H.L. Leonard Risk-benefit decision for treatment of depression during pregnancy Am J Psychiatry 157 2000 1933 1940
2. H.A. Bennett, A. Einarson, A. Taddio, G. Koren, and T.R. Einarson Prevalence of depression during pregnancy: systematic review Obstet Gynecol 103 2004 698 709
3. A. Einarson, P. Selby, and G. Koren Abrupt discontinuation of psychotropic drugs due to fears of teratogenic risk and the impact of counseling J Psychiatry Neurosci 26 2001 44 48
4. H. Michel-Wolfromm The psychological factor in spontaneous abortion J Psychosom Res 12 1968 67 71
5. M. Zax, A.J. Sameroff, and H.M. Babigian Birth outcomes in the offspring of mentally disordered women Am J Orthopsychiatry 47 1977 218 230
6. T. Field, M. Diego, M. Hernandez-Reif, F. Salman, S. Schanberg, and C. Kuhn Prenatal anger effects on the fetus and neonate J Obstet Gynaecol 22 2002 260 266
7. S. Hoffman, and M.C. Hatch Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women Health Psychol 19 2000 535 543
8. A. Preti, L. Cardacia, T. Zen, P. Pellizzari, M. Marchetti, and G. Favaretto Obstetric complications in patients with depression: a population-based case-control study J Affect Disord 61 2000 101 106
9. J. Dayan, C. Creveuil, M. Herlicoviez, C. Herbel, E. Baranger, and C. Savoye Role of anxiety and depression in the onset of spontaneous preterm labor Am J Epidemiol 155 2002 293 301
10. S.T. Orr, S.A. James, and P.C. Blackmore Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland Am J Epidemiol 156 2002 797 802
11. Better news on population (notice board) Lancet 339 1992 16
12. J. Willetts, A. Lippa, and B. Beer Clinical development of citalopram J Clin Psychopharmacol 19 5 Suppl 1 1999 36S 46S
13. 2004 IMS HEALTH Canada. Treating depression with SSRIs. Available from: http://www.imshealthcanada.com/.htmen/1_0_14.htm (Accessed November 2, 2004).
14. Celexa product monograph 1999 Lundbeck Canada Inc Montreal
15. T. Heikkinen, U. Ekblad, and K. Laine Transplacental transfer of citalopram, fluoxetine and their primary metabolites in isolated perfused human placenta BJOG 109 2002 1003 1008
16. V. Hendrick, Z. Stowe, L. Altshuler, S. Hwang, E. Lee, and D. Haynes Placental passage of antidepressant medications Am J Psychiatry 160 2003 993 996
17. Tabacova SA, McCloskey CA, Fisher JE. Adverse developmental events to FDA in association with maternal citalopram treatment in pregnancy. Rockville (MD): Center for Drug Evaluation and Research, U.S. Food and Drug Administration.
18. T. Heikkinen, U. Ekblad, P. Kero, S. Ekblad, and K. Laine Citalopram in pregnancy and lactation Clin Pharmacol Ther 72 2002 184 191
19. V. Hendrick, L.M. Smith, R. Suri, S. Hwang, D. Haynes, and L. Altshuler Birth outcomes after prenatal exposure to antidepressant medication Am J Obstet Gynecol 188 2003 812 815
20. A. Ericson, B. Kallen, and B.-E. Wiholm Delivery outcome after the use of antidepressants in early pregnancy Eur J Clin Pharmacol 55 1999 503 508
21. I. Nulman, J. Rovet, D.E. Stewart, J. Wolpin, H.A. Gardner, and J.G. Theis Neurodevelopment of children exposed in utero to antidepressant drugs N Engl J Med 336 1997 258 262
22. I. Nulman, J. Rovet, D.E. Stewart, J. Wolpin, P. Pace-Asciak, and S. Shuhaiber Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study Am J Psychiatry 159 2002 1889 1895
23. N. Kulin, A. Pastusazak, S. Sage, B. Schick-Boschetto, G. Spivey, and M. Feldkamp Pregnancy outcome following maternal use of the new serotonin reuptake inhibitors: a prospective multicenter study JAMA 279 1998 609 610
24. A. Einarson, B. Fatoye, M. Sarkar, S.V. Lavigne, J. Brochu, and C. Chambers Pregnancy outcome following gestational exposure to venlafaxine Am J Psychiatry 158 2001 1728 1730
25. R.C. Casper, B.G. Fleisher, J.C. Lee-Ancajas, A. Gilles, E. Gaylor, and A. DeBattista Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy J Pediatr 142 2003 402 408
26. A. Pastuszak, B. Schick-Boschetto, C. Zuber, M. Feldkamp, M. Pinelli, and A. Donnenfeld Pregnancy outcome following first trimester exposure to fluoxetine JAMA 269 1993 2246 2248
27. B. Zuckerman, H. Amaro, H. Bauchner, and H. Cabral Depressive symptoms during pregnancy: relationship to poor health behaviors Am J Obstet Gynecol 160 5 Pt 1 1989 1107 1111
28. C.D. Chambers, K.A. Johnson, L.M. Dick, R.J. Felix, and K.L. Jones Birth outcomes in pregnant women taking fluoxetine N Engl J Med 335 1996 1010 1015
29. A.M. Costei, E. Kozer, T. Ho, S. Ito, and G. Koren Perinatal outcome following third trimester exposure to paroxetine Arch Pediatr Adolesc Med 156 2002 1129 1132
30. B. Källén Neonate characteristics after maternal use of antidepressants in late pregnancy Arch Pediatr Adolesc Med 158 2004 312 316
31. H. Nordeng, R. Lindemann, K.V. Perminov, and A. Reikvam Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors Acta Paediatr 90 2001 288 291
32. T.F. Oberlander, S. Misri, C.E. Fitzgerald, X. Kostaras, D. Rurak, and W. Riggs Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure J Clin Psychiatry 65 2004 230 237
33. J.S. Markowitz, C.L. DeVane, H.L. Liston, and S.A. Montgomery An assessment of selective reuptake inhibitor discontinuation symptoms with citalopram Int Clin Psychopharmacol 15 2000 329 333